Literature DB >> 23706981

Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.

Hermann Brenner1, Sha Tao.   

Abstract

There is increasing evidence that faecal immunochemical tests (FITs) for haemoglobin offer a number of advantages over traditional guaiac based faecal occult blood tests (gFOBTs). However, evidence on diagnostic performance from direct comparisons with colonoscopy findings in all participants in the average risk population is still sparse. We aimed for a head-to-head comparison of three quantitative FITs with a gFOBT among participants of the German screening colonoscopy programme. Pre-colonoscopy stool samples and colonoscopy reports were obtained from 2235 participants of screening colonoscopy in 2005-2009. To enhance comparability of diagnostic performance of the various tests, we assessed sensitivity, specificity, predictive values and likelihood ratios of FITs after adjusting the FIT cut-off haemoglobin (Hb) concentrations in such a way that FIT positivity rates equalled the positivity rate of the gFOBT. Colorectal cancer, advanced adenomas and other adenomas were found in 15 (0.7%), 207 (9.3%) and 398 (17.8%) participants. The gFOBT was positive in 111 (5.0%) participants, with sensitivities (specificities) for detecting colorectal cancer, any advanced neoplasm or any neoplasm of 33.3% (95.2%), 8.6% (95.4%) and 5.5% (95.2%). At the same positivity rate, all three FITs outperformed the gFOBT in all indicators. In particular, all sensitivities of FITs were approximately two to three times higher at increased levels of specificity. All differences were statistically significant, except for some of the performance indicators for colorectal cancer. In conclusion, FITs can detect much larger proportions of colorectal neoplasms even if their cut-offs are set to levels that ensure equally low positivity rates as gFOBT.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Faecal occult blood test; Immunochemical; Screening; Sensitivity; Specificity

Mesh:

Substances:

Year:  2013        PMID: 23706981     DOI: 10.1016/j.ejca.2013.04.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  80 in total

1.  Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program.

Authors:  Ding Ye; Qiuchi Huang; Qilong Li; Xiyi Jiang; Mayila Mamat; Mengling Tang; Jianbing Wang; Kun Chen
Journal:  Dig Dis Sci       Date:  2017-06-20       Impact factor: 3.199

Review 2.  Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy.

Authors:  Ethna McFerran; James F O'Mahony; Richard Fallis; Duncan McVicar; Ann G Zauber; Frank Kee
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

3.  Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.

Authors:  Hermann Brenner; Silvia Calderazzo; Thomas Seufferlein; Leopold Ludwig; Nektarios Dikopoulos; Jörg Mangold; Wolfgang Böck; Thomas Stolz; Thomas Eisenbach; Thomas Block; Annette Kopp-Schneider; David Czock; Kaja Tikk
Journal:  JAMA       Date:  2019-05-07       Impact factor: 56.272

4.  Screening for Bowel Cancer: Increasing Participation via Personal Invitation.

Authors:  Michael Hoffmeister; Bernd Holleczek; Nadine Zwink; Christian Stock; Christa Stegmaier; Hermann Brenner
Journal:  Dtsch Arztebl Int       Date:  2017-02-10       Impact factor: 5.594

Review 5.  Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.

Authors:  Jeffrey K Lee; Elizabeth G Liles; Stephen Bent; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

6.  Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

Authors:  Iris Lansdorp-Vogelaar; S Lucas Goede; Linda J W Bosch; Veerle Melotte; Beatriz Carvalho; Manon van Engeland; Gerrit A Meijer; Harry J de Koning; Marjolein van Ballegooijen
Journal:  Clin Gastroenterol Hepatol       Date:  2017-07-18       Impact factor: 11.382

7.  Fecal immunochemical test-based colorectal cancer screening: The gender dilemma.

Authors:  Esmée J Grobbee; Els Wieten; Bettina E Hansen; Esther M Stoop; Thomas R de Wijkerslooth; Iris Lansdorp-Vogelaar; Patrick M Bossuyt; Evelien Dekker; Ernst J Kuipers; Manon Cw Spaander
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

8.  Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.

Authors:  Efrat L Amitay; Agne Krilaviciute; Hermann Brenner
Journal:  Gut Microbes       Date:  2018-05-15

Review 9.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

Review 10.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.